Drug Shortage Report for CYCLOMEN
Report ID | 80353 |
Drug Identification Number | 02018152 |
Brand name | CYCLOMEN |
Common or Proper name | Cyclomen 100 mg |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DANAZOL |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G03XA |
ATC description | OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-03-15 |
Estimated end date | 2019-12-02 |
Actual end date | 2019-06-25 |
Shortage status | Resolved |
Updated date | 2019-06-26 |
Company comments | Delay in manufacturing June 25, 2019: A small quantity of Cyclomen 100 mg (DIN 02018152) has been secured and is now released. Allocation will be made for pending POs based on ordering history |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-04-03 | English | Compare |
v2 | 2019-04-03 | French | Compare |
v3 | 2019-06-14 | English | Compare |
v4 | 2019-06-14 | French | Compare |
v5 | 2019-06-26 | English | Compare |
v6 | 2019-06-26 | French | Compare |
Showing 1 to 6 of 6